Enquiry/Quote
Ipratropium Bromide bulk supplier for pharma manufacturers

Ipratropium Bromide Suppliers & Bulk Manufacturers

Available Forms: Inhalation solution

Available Strengths: 17 mcg

Reference Brands: Atrovent (USA)

Category: Respiratory Disorder

Ipratropium Bromide is available in Inhalation solution and strengths such as 17 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ipratropium Bromide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Ipratropium Bromide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Ipratropium bromide is an anticholinergic bronchodilator and nasal spray used to manage a variety of respiratory conditions. Administered via inhaler, nebulizer, or nasal spray, it helps open the medium and large airways in the lungs and reduces nasal secretions. The inhalation forms are primarily used to treat symptoms of chronic obstructive pulmonary disease (COPD) and asthma, producing bronchodilation by inhibiting muscarinic receptors in the airways. Onset of action occurs within 15 to 30 minutes, with effects lasting approximately three to five hours. While somewhat less potent than beta-2 agonists in asthma, ipratropium is equally effective in bronchitis and provides longer-duration relief. Combination therapy with beta-2 agonists, theophylline, or sodium cromoglycate can enhance therapeutic outcomes due to complementary mechanisms of action.

The nasal spray formulation prevents the nasal glands from producing excessive fluid, providing relief from rhinorrhea associated with allergic rhinitis, nonallergic rhinitis, and the common cold. Administered via a metered-dose manual pump, its onset of action is typically within one hour, making it an effective option for controlling nasal congestion and runny nose symptoms. Ipratropium bromide offers flexible administration routes to address both lower and upper airway conditions effectively.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions


Ipratropium bromide is used to treat and manage chronic obstructive pulmonary disease (COPD), asthma, and other respiratory conditions involving bronchospasm. It helps open the airways, making breathing easier and reducing symptoms such as wheezing, shortness of breath, and coughing.


Ipratropium bromide is a chemically synthesized anticholinergic compound formulated for inhalation as a metered-dose inhaler, nebulizer solution, or combination therapy with bronchodilators.


Trade names include Atrovent and Combivent.


Ipratropium bromide is manufactured and marketed by multiple pharmaceutical companies, including Boehringer Ingelheim and licensed generic manufacturers.


The generic name is ipratropium bromide.


Brand names include Atrovent and Combivent.


Ipratropium bromide is manufactured in FDA-, EMA-, and MHRA-approved pharmaceutical facilities under strict quality control standards for inhalation therapies.

Yes, Ipratropium Bromide is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Ipratropium Bromide is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Ethionamide

Strength:
250 mg

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details
Olodaterol

Strength:
2.5 mcg

Form: Inhalation solution

Reference Brands: Striverdi Respimat (USA)

View Details
Methacholine Chloride

Strength:
0.25 mg/mL, 0.5 mg/mL, 1 mg/mL, 2 mg/mL

Form: Inhalation solution

Reference Brands: Provocholine (USA)

View Details
Metaproterenol Sulfate

Strength:
10 mg, 15 mg,5 mg/5 m

Form: Tablet / Syrup / Inhalation Solution

Reference Brands: Generic formulations marketed under different names

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.